2018
DOI: 10.1302/2046-3758.73.bjr-2017-0270.r1
|View full text |Cite
|
Sign up to set email alerts
|

A review of biomaterials in bone defect healing, remaining shortcomings and future opportunities for bone tissue engineering

Abstract: Despite its intrinsic ability to regenerate form and function after injury, bone tissue can be challenged by a multitude of pathological conditions. While innovative approaches have helped to unravel the cascades of bone healing, this knowledge has so far not improved the clinical outcomes of bone defect treatment. Recent findings have allowed us to gain in-depth knowledge about the physiological conditions and biological principles of bone regeneration. Now it is time to transfer the lessons learned from bone… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
254
0
10

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 365 publications
(270 citation statements)
references
References 118 publications
2
254
0
10
Order By: Relevance
“…Allografts are also similarly histocompatible and available in various forms, including demineralized bone matrices, cancellous chips, cortico‐cancellous and cortical grafts and osteochondral and whole‐bone segments, depending on the host site's requirements (Finkemeier, ). In comparison with autografts, allografts are associated with risks of immunoreactions and transmission of infections and have numerous proven records of high failure rates over long‐term use (De Grado et al., ; Winkler, Sass, Duda, & Schmidt‐Bleek, ). Allografts are devitalized (and often sterilized) mainly through decalcification, deproteinization, irradiation and/or freeze‐drying processing; they therefore lack cells and have reduced osteoinductive properties (Wheeler & Enneking, ; Delloye, Cornu, Druez, & Barbier, ).…”
Section: Review Of Current Literaturementioning
confidence: 99%
“…Allografts are also similarly histocompatible and available in various forms, including demineralized bone matrices, cancellous chips, cortico‐cancellous and cortical grafts and osteochondral and whole‐bone segments, depending on the host site's requirements (Finkemeier, ). In comparison with autografts, allografts are associated with risks of immunoreactions and transmission of infections and have numerous proven records of high failure rates over long‐term use (De Grado et al., ; Winkler, Sass, Duda, & Schmidt‐Bleek, ). Allografts are devitalized (and often sterilized) mainly through decalcification, deproteinization, irradiation and/or freeze‐drying processing; they therefore lack cells and have reduced osteoinductive properties (Wheeler & Enneking, ; Delloye, Cornu, Druez, & Barbier, ).…”
Section: Review Of Current Literaturementioning
confidence: 99%
“…The rapid advance of tissue engineering has meant that certain biodegradable and biocompatible polymers such as poly( l ‐lactide) (PLLA), polycaprolactone (PCL), poly( l ‐lactide ‐co ‐caprolactone) (PLCL), and poly( l ‐lactide ‐co ‐glycolide) (PLGA) are now used to produce scaffolds for the regeneration of bone tissue . Scaffold production is relatively easy with these polymers using different techniques: thermally induced phase separation (TIPS), particulate‐leaching techniques, and electrospinning, and so on.…”
Section: Introductionmentioning
confidence: 99%
“…Despite numerous studies focusing on preparation of bone tissue engineering scaffolds and comprehensive investigations of different scaffold component combinations, there is still muchneeded improvements necessary for integrating bone tissue engineering scaffolds for in-vivo studies with potential significantly superior clinical outcomes [13]. Such shortcomings are particularly evident in studies with a major or minor focus on electrical stimulation of bone cells or tissue prior or after implantation [14][15].…”
Section: Introductionmentioning
confidence: 99%